Streptomyces cinnamonensis Okami (ATCC® 15413)

Strain Designations: A 3823  /  Type Strain: no  /  Biosafety Level: 1

Strain Designations A 3823
Produces A3823A antibiotic A3823A
Produces phenazine-carboxylic acids
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 30.0°C
Name of Depositor Eli Lilly & Co.

Haney ME, et al. Novel antibiotic A3823 complex and process for production thereof. US Patent 3,501,568 dated Mar 17 1970

Karnetova J, et al. Production of phenazines by Streptomyces cinnamonensis. Folia Microbiol. 28: 51-53, 1983. PubMed: 6832658

Collect. Czech. Chem. Commun. 48: 527-532, 1983.

Valentin HE, Dennis D. Metabolic pathway for poly(3-hydroxybutyrate-co-3-hydroxyvalerate) formation in Nocardia corallina: inactivation of mutB by chromosomal integration of a kanamycin resistance gene. Appl. Environ. Microbiol. 62: 372-379, 1996. PubMed: 8593043